BIT Group to Display Molecular Instrumentation Solutions at AMP 2017

BIT Group will display three molecular instrument solutions at the AMP 2017 Annual Meeting (taking place November 16-18 at the Calvin L. Rampton Salt Place Convention Center in Salt Lake City, Utah). At BIT’s Booth #626, attendees will be able to investigate a medium-sized Molecular Genotyping Platform as well as two compact molecular diagnostic testing instruments within the fast-growing Rapid Diagnostic POC Testing Solutions field.

SALT LAKE CITY--(BUSINESS WIRE)--BIT Group (exhibiting at Booth #626) will present three molecular instrumentation solutions at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, November 16-18. Each instrument will showcase a different technology. The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence. Nearly 200 globally diverse exhibitors will represent every aspect of molecular diagnostics. Key executive members of BIT’s Global Business Development team will be at Booth #626 to field questions regarding one medium-sized automated molecular genotyping platform; and two compact Rapid Diagnostic POC Testing Instruments (from BIT partners Lucigen and Qorvo) as well as to discuss potential new projects. Anyone interested in scheduling a private meeting is encouraged to email BIT at [e-mail].

Detailed descriptions of the showcased instruments –– include:

• Automated Molecular Genotyping Platform
  This medium-sized platform (based on a fluorescence-labeled, bead chip technology) is designed for transfusion, pharmacological and transplantation assays.

• Qorvo Universal Bio-Sensor System/ Cartridge Platform
  This compact Rapid Diagnostic POC Testing Solution is designed for processing immunoassays while allowing for broad test & sample flexibility.
• Lucigen In-vitro Diagnostic LAMP-based Platform
  This compact Rapid Diagnostic POC Testing Solution is designed for isothermal amplification and detection of various pathogens or nucleic acid analytes. It utilizes BIT POC SMARTModules.

BIT Group provides contract product development, manufacturing and after-sales services, as well as hematology instruments, for life science, medical and IVD instrumentation OEMs. Quality and regulatory standards include GMP, FDA registered, ISO13485, QSR and CE IVD Directive. BIT Group‘s global operations in USA, Germany, France & China deliver precision engineered, cost effective systems solutions. Pre-engineered platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.